Back
Monster Beverage 10K Form
Buy
51
MNST
Monster Beverage
Last Price:
$63.4300
Seasonality Move:
6.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | MNST/Monster Beverage Quarterly |
2023-11-06 | 10Q | MNST/Monster Beverage Quarterly |
2023-08-04 | 10Q | MNST/Monster Beverage Quarterly |
2023-05-05 | 10Q | MNST/Monster Beverage Quarterly |
2022-11-04 | 10Q | MNST/Monster Beverage Quarterly |
2022-08-05 | 10Q | MNST/Monster Beverage Quarterly |
Receive MNST News And Ratings
See the #1 stock for the next 7 days that we like better than MNST
MNST Financial Statistics
Sales & Book Value
Annual Sales: | $7.5B |
---|---|
Cash Flow: | $473.2M |
Price / Cash Flow: | 35.92 |
Annual Sales: | $6.69 |
Price / Book: | 9.49 |
Profitability
EPS (TTM): | 1.62000 |
---|---|
Net Income (TTM): | $1.5B |
Gross Margin: | $4B |
Return on Equity: | 23.09% |
Return on Assets: | 17.91% |
Monster Beverage Earnings Forecast
Key Monster Beverage Financial Ratios
-
The Gross Profit Margin over the past 33 years for MNST is 54.04%.
-
The Selling, General & Administrative Expenses for MNST have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of MNST is 20.14% of Total Revenues.
-
Per Share Earnings over the last 35 years have been positive in 24 years.
Monster Beverage Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Beverages |
Sector: | Consumer Staples |
Current Symbol: | MNST |
CUSIP: | 61174X |
Website: | monsterbevcorp.com |
Debt
Debt-to-Equity Ratio: | 0.03 |
---|---|
Current Ratio: | 3.37 |
Quick Ratio: | 2.66 |
Price-to-Earnings
Trailing P/E Ratio: | 42.56 |
---|---|
Forward P/E Ratio: | 30.71 |
MNST Technical Analysis vs Fundamental Analysis
Buy
51
Monster Beverage (MNST)
is a Buy
Is Monster Beverage a Buy or a Sell?
-
Monster Beverage stock is rated a BuyThe current Monster Beverage [MNST] share price is $63.4100. The Score for MNST is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.